Related Experiment Video
Updated: May 20, 2026
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Lithium Attenuates Brain Injury and Inflammation in Neonatal Rats with Germinal Matrix Hemorrhage
Jing Yuan1, Xiaoli Zhang1, Yu Yang1
1Henan Key Laboratory of Child Brain Injury and Henan Pediatric Clinical Research Center, Third Affiliated Hospital and Institute of Neuroscience of Zhengzhou University, Zhengzhou, China.
Insights
Lithium treatment significantly reduced brain injury and inflammation in a neonatal rat model of germinal matrix hemorrhage (GMH). This suggests lithium
Area of Science:
- Neuroscience
- Neonatal Research
- Pharmacology
Background:
- Germinal matrix hemorrhage (GMH) is a primary cause of mortality and long-term neurodevelopmental deficits in extremely preterm infants.
- Effective therapeutic strategies to mitigate GMH-induced brain injury are critically needed.
Purpose of the Study:
- To investigate the neuroprotective potential of lithium in a neonatal rat model of germinal matrix hemorrhage (GMH).
- To evaluate lithium's effects on brain injury, white matter integrity, inflammation, and neurobehavioral outcomes.
Main Methods:
- GMH was induced in P5 Sprague-Dawley rats using collagenase injections.
- Lithium chloride (LiCl) was administered intraperitoneally post-injury.
- Brain injury, white matter integrity, inflammation, and neurobehavioral outcomes were assessed via MRI, histology, behavioral tests, and molecular analyses.
Main Results:
- Lithium treatment significantly reduced lesion volume by 37% and improved hippocampal white matter integrity.
- Lithium administration alleviated anxiety-like behaviors and enhanced neural stem cell proliferation and oligodendrocyte survival.
- Molecular analyses revealed lithium modulated neuroinflammatory (reduced IL-1β) and neurotrophic pathways (increased GSK-3β phosphorylation, BDNF, Cyclin D1).
Conclusions:
- Lithium demonstrates significant neuroprotective effects in a neonatal rat model of GMH.
- The therapeutic benefits are likely mediated by the modulation of neuroinflammation, promotion of neurogenesis, and regulation of key molecular pathways.
- These findings highlight lithium's translational potential for improving outcomes in preterm infants affected by GMH.
Introduction/Objective:
Germinal matrix hemorrhage (GMH) is a major cause of mortality and neurodevelopmental disability in very preterm infants (<32 gestation weeks). This study evaluated lithium's neuroprotective effects in a neonatal rat model of GMH.
Methods:
GMH was induced in postnatal day (P) 5 Sprague-Dawley rats via collagenase injections. Lithium chloride (LiCl) was administered intraperitoneally at 2 mmol/kg 6 hours post-injury, followed by 1 mmol/kg/day until P11. Brain injury, white matter integrity, inflammation, and neurobehavioral outcomes were assessed using MRI, histology, behavioral tests, and molecular analyses for key markers. A total of 107 pups were included.
Results:
Lithium treatment reduced ipsilateral lesion volume by 37% (p < 0.01), improved fractional anisotropy in the hippocampus at P40 (p < 0.001), and alleviated anxiety-like behavior (p = 0.0089). It enhanced neural stem cell proliferation, supported oligodendrocyte survival, and reduced activation of microglia (Iba-1+ /CD68+ ) and astrocytic (GFAP+ ) (all p < 0.001). Molecular analyses showed increased phosphorylation of GSK-3β levels (p = 0.0002), elevated BDNF (p = 0.0108) and Cyclin D1 expression (p = 0.0183), and reduced IL-1β (p = 0.0025), indicating lithium modulates neuroinflammatory and neurotrophic pathways.
Discussion:
These findings support the role of lithium in mitigating brain injury after GMH, likely through the modulation of neuroinflammation, promotion of neurogenesis, and modulation of key molecular pathways (GSK-3β, BDNF, Cyclin D1, IL-1β), highlighting its translational promise.
Conclusion:
Lithium mitigates brain injury and neuroinflammation after GMH in neonatal rats, likely via GSK-3β inhibition and BDNF-mediated signaling. These findings highlight lithium's therapeutic potential for improving outcomes in preterm infants.
